Eli Lilly agrees to pay nearly US$700 million to settle Zyprexa label claims

INDIANAPOLIS (AP) - Eli Lilly & Co. has agreed to pay nearly $700 million US to settle a majority of legal claims that labels on its anti-psychosis drug Zyprexa had failed to provide adequate warning that the drug could put patients more at risk for developing diabetes....More